Medicine
V. Martínez, J. González-Juanatey
tlooto Summary
When used in combination with other established biomarkers for the prediction of the first major cardiovascular event or death, CRP does not improve the risk stratification obtained with the current guidelines.
Abstract
Abstract is not available.
Citation format
MARTÍNEZ, V.; GONZÁLEZ-JUANATEY, J. Markers of inflammation and cardiovascular disease. American Journal of Cardiovascular Drugs, 2009, 9: 3–7.